![]() |
|
|
Forward to a colleague |
||
Access Full Stories It might be years away yet, but men could be the ones popping a pill for contraception if GTx has anything to do with it... Read Biovail knocked back by FDA decision Canadian firm Biovail has been thrown another curveball by US regulators as the resubmission for its antidepressant candidate is handed Class 2 status, delaying approval for at least another six months... Read Puerto Rico's problems piling up Pfizer's revelation this week that it plans to slice jobs in Puerto Rico is the latest in a string of blows for this popular offshore manufacturing location... Read Pandemic flu vaccine supply inadequate, says report The current state of pandemic influenza vaccine supplies and capacity is shockingly insufficient, a new report has found - less than one-fifth of needed doses would actually be available within six months of an... Read Pharmaceutical manufacturing: people on the move Alfacell, Phoqus Pharmaceuticals, Watson Pharmaceuticals, Stem Cell Sciences, Kythera Biopharmaceuticals and ISPE have all had people on the move in the world of pharmaceutical manufacturing... Read |
||||||||||||||
All News Headlines for: November | October | September |
||||||||||||||
Upgrading pharmaceutical production with new bulk excipients Are you looking for a new bulk excipient to facilitate wet granulation or compaction? The new galenIQ™ 800 series offers tailor-made powder grades to upgrade your agglomeration process... Click Here | ||||||||||||||
|
Related Industry News Evolution study finds 300 new genes A supercomputer designed to root out genes that have been conserved over millions of years of evolution has discovered 300 new human genes... Read Covance rescues Eli Lilly's forgotten facility Covance has acquired a partially constructed facility from Eli Lilly and plans to invest $175m (€118m) to convert it into a drug development laboratory to meet demand from its biopharmaceutical customers... Read No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma... Read Merck turns to India for latest R&D partnership Merck & Co. has turned to India's Nicholas Piramal (NPIL) for its latest research collaboration, as the preclinical offshoring trend persists... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||